| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | JOHNSON & JOHNSON CMN | Sep 25, 2026 | |
| Buy | Johnson & Johnson Common Sto | Sep 8, 2026 | |
| Buy | JOHNSON & JOHNSON CMN | Sep 4, 2026 | |
| Sell | Johnson & Johnson Common Sto | Aug 27, 2026 | |
| Sell | Johnson & Johnson Common Sto | Aug 20, 2026 | |
| Sell | JOHNSON & JOHNSON CMN | Aug 7, 2026 | |
| Sell | Johnson & Johnson Common Sto | Jul 30, 2026 | |
| Sell | Johnson & Johnson Common Sto | Jun 29, 2026 | |
| Sell | JOHNSON & JOHNSON CMN | Jun 16, 2026 | |
| Buy | Johnson & Johnson Common Sto | Jun 9, 2026 |
This page tracks congressional stock trading activity in Johnson & Johnson (JNJ) in the Healthcare sector. Disclosed Capitol has indexed 639 disclosed congressional trades involving JNJ. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of October 2026 — Disclosed Capitol has tracked 639 disclosed congressional trades in Johnson & Johnson (JNJ) — 346:279 buy-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Sep 25, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Sep 8, 2026 | Lloyd Doggett | D | Buy | $1,001 - $15,000 |
| Sep 4, 2026 | Ro Khanna | D | Buy | $15,001 - $50,000 |
| Aug 27, 2026 | Thomas H. Kean | R | Sell | $1,001 - $15,000 |
| Aug 20, 2026 | John Boozman | R | Sell | $1,001 - $15,000 |
| Aug 7, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Jul 30, 2026 | Richard Dean Dr McCormick | R | Sell | $1,001 - $15,000 |
| Jun 29, 2026 | Thomas H. Kean | R | Sell | $1,001 - $15,000 |
| Jun 16, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Jun 9, 2026 | Lloyd Doggett | D | Buy | $1,001 - $15,000 |
Across the 639 disclosed congressional trades in Johnson & Johnson (JNJ), members of Congress have reported 346 buys and 279 sells. The average 30-day alpha vs. the S&P 500 is -1.41%.
As of November 2025, corporate insiders at Johnson & Johnson have filed 2 SEC Form 4 transactions in JNJ over the past 12 months — including 2 sells worth $224K.
| Date | Insider | Action | Value |
|---|---|---|---|
| 2025-11-26 | Johnson & Johnson Innovation - JJDC, Inc. | Sale | $64K |
| 2025-11-25 | Johnson & Johnson Innovation - JJDC, Inc. | Sale | $160K |
Insider transactions are parsed from SEC Form 4 filings and shown alongside the congressional trades above. Institutional 13F positions are tracked separately on the institutional holdings page.
As of September 2026, Johnson & Johnson has 8,054 federal contract award records on file from USAspending.gov — most recently $100K from the Department of Health and Human Services on 2026-09-21.
| Award date | Agency | Amount |
|---|---|---|
| 2026-09-21 | Department of Health and Human Services · Indian Health Service | $100K |
| 2026-09-21 | Department of Health and Human Services · Indian Health Service | $100K |
| 2026-09-02 | Department of Veterans Affairs | $385K |
| 2026-08-17 | Department of Veterans Affairs | $109K |
| 2026-08-17 | Department of Veterans Affairs | $109K |
| 2026-07-01 | Department of Homeland Security · Federal Emergency Management Agency | $859K |
| 2026-07-01 | Department of Health and Human Services · National Institutes of Health | $60K |
| 2026-07-01 | Department of Defense · Defense Logistics Agency | $62K |
| 2026-07-01 | Department of Defense · Defense Logistics Agency | $56K |
| 2026-06-30 | Department of Veterans Affairs | $100K |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, Johnson & Johnson reported revenue of $94.19B and net income of $26.80B, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $25.31B, net income $5.53B.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.